Jian Hua Mo
Direktor/Vorstandsmitglied bei HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD
Vermögen: 173 Mio $ am 30.04.2024
Aktive Positionen von Jian Hua Mo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD | Direktor/Vorstandsmitglied | 01.05.2012 | - |
| Corporate Officer/Principal | 01.01.2003 | 01.05.2012 | |
| BINJIANG SERVICE GROUP CO. LTD. | Direktor/Vorstandsmitglied | 01.12.2017 | - |
| Shanghai Binshun Investment Management Ltd | Direktor/Vorstandsmitglied | - | - |
| Hangzhou Binpu Real Estate Development Ltd. | Direktor/Vorstandsmitglied | - | - |
| Corporate Officer/Principal | - | - | |
| Hangzhou Pute Equity Investment Management Ltd. | Corporate Officer/Principal | 01.01.2017 | - |
Karriereverlauf von Jian Hua Mo
Ehemalige bekannte Positionen von Jian Hua Mo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Hangzhou Binjiang Venture Captal Investment Ltd. | Corporate Officer/Principal | 01.05.2011 | 01.11.2017 |
| Hangzhou Binjiang Real Estate Construction Co. Ltd. | Corporate Officer/Principal | 01.08.1996 | 01.12.1999 |
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
 Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Direktor/Vorstandsmitglied | 08.04.2011 | - |
Ausbildung von Jian Hua Mo
| Zhejiang University | Masters Business Admin |
Statistik
International
| China | 9 |
| Cayman Islands | 2 |
Operativ
| Director/Board Member | 5 |
| Corporate Officer/Principal | 5 |
| Masters Business Admin | 1 |
Sektoral
| Finance | 3 |
| Consumer Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD | Finance |
| BINJIANG SERVICE GROUP CO. LTD. | Finance |
| Private Unternehmen | 6 |
|---|---|
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Health Technology |
| Shanghai Binshun Investment Management Ltd | |
| Hangzhou Binpu Real Estate Development Ltd. | |
| Hangzhou Pute Equity Investment Management Ltd. | |
| Hangzhou Binjiang Venture Captal Investment Ltd. | |
| Hangzhou Binjiang Real Estate Construction Co. Ltd. |
- Börse
- Insiders
- Jian Hua Mo
- Erfahrung
